Hosted on MSN7d
Google DeepMind CEO says 2025's the year we start popping pills AI helped invent
Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...
Will Google's DeepMind Be Threatened By DeepSeek? Wait And See
Google's DeepMind leads the market with Gemini, TPU chips, and cloud growth, making its valuations compelling compared to its ...
Google-backed, AI-developed drugs are headed to trial by 2026, DeepMind CEO says
Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.
ReadWrite7d
Trials of drugs developed with AI could begin this year, Google DeepMind CEO says
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
Microsoft’s relationship with OpenAI cracked when it hired Mustafa Suleyman, rival Marc Benioff says
Salesforce CEO Marc Benioff said that the two AI leaders, Sam Altman and Mustafa Suleyman do not care for each other.
NextBigFuture5d
Demis Hassabis Thinks Searching Knowledge Is Needed for Superintelligent AI
Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...
MIT Technology Review5d
OpenAI launches Operator—an agent that can use a computer for you
The announcement confirms one of two rumors that circled the internet this week. The other was about superintelligence.
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.